Could a simple protein improve recovery from aggressive cancer surgery?
NCT ID NCT06351475
First seen Jan 04, 2026 · Last updated Jun 20, 2026 · Updated 27 times
Summary
This study tests whether adding a protein called albumin to standard IV fluids during a major cancer surgery (cytoreduction with heated chemotherapy) can reduce complications. The surgery causes large fluid shifts, and the trial aims to see if albumin helps patients recover better. 140 adults with peritoneal cancer are being randomly assigned to receive either standard fluids or standard fluids plus albumin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE COMPLICATIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gustave Roussy Institute
RECRUITINGVillejuif, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Hautepierre / UIC ARMO
RECRUITINGStrasbourg, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut régional du Cancer de Montpellier
RECRUITINGMontpellier, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
La Pitié Salpetriere hospital
RECRUITINGParis, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lariboisière hospital
RECRUITINGParis, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Robert Debré hospital
RECRUITINGReims, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Saint Louis hospital
RECRUITINGParis, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
20% human albumin combined with Ringer's lactate solution
What this could lead to
If it works, this could lead to a standard fluid therapy that reduces serious complications after major abdominal cancer surgery.
What could go wrong
This is a relatively small, early-stage trial (140 patients) and the benefit of albumin in surgery is unproven. There is also a risk of allergic reactions or fluid overload with albumin.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.